|
2026
|
Invention
|
Substituted tricyclic compounds.
Disclosed are compounds of the general formula (I), its tautome... |
|
2025
|
Invention
|
Oral formulation of pimavanserin. The invention relates to stable oral formulations of pimavanser... |
|
|
Invention
|
Liquid compositions of valbenazine for oral administration. The present invention relates to a st... |
|
|
Invention
|
A process for processing micronized active pharmaceutical ingredients. A novel process for proces... |
|
|
Invention
|
Pharmaceutical composition of edaravone. The present invention relates to stable composition of e... |
|
|
Invention
|
The novel rizatriptan nasal spray compositions. The present invention provides the following aspe... |
|
|
Invention
|
Tenofovir alafenamide compositions. The present invention provides oral pharmaceutical compositio... |
|
|
Invention
|
Pharmaceutical formulation of anti-pd-1 antibody. The present invention discloses a pharmaceutica... |
|
|
P/S
|
Printed matter and publications namely articles, newsletters, flyers, magazines, and manuals in t... |
|
|
Invention
|
Stable ophthalmic pharmaceutical formulation of aflibercept. The present invention relates to sta... |
|
|
Invention
|
Stable pharmaceutical compositions of dalbavancin as ready-to-dilute formulation. The present inv... |
|
|
Invention
|
Pharmaceutical formulation of anti-il-5 antibody. The present invention relates to pharmaceutical... |
|
2024
|
Invention
|
Stable topical cream formulation of clascoterone. The invention provides a stable topical cream f... |
|
|
P/S
|
Inhalers used for the treatment of respiratory ailments; inhalers filled with pharmaceutical prep... |
|
|
Invention
|
Ion-exchange chromatography for separation and analysis of charge variants. The present invention... |
|
|
P/S
|
Pharmaceuticals, namely, contraceptives, oral contraceptives, and oral hormonal contraceptives; c... |
|
|
P/S
|
Pharmaceutical preparations for use in pregnancy termination |
|
|
Invention
|
Stable pharmaceutical composition of methylnaltrexone for an oral administration.
The present in... |
|
|
P/S
|
Biological preparations for the treatment of eye conditions, namely, to slow down loss of eye sig... |
|
|
Invention
|
Solid dispersion of rifaximin.
A solid dispersion of rifaximin comprising rifaximin and pharmace... |
|
|
Invention
|
Process for manufacturing antibody fragment protein.
The invention provides a process for manufa... |
|
|
Invention
|
Process for manufacturing antibody fragment protein. The invention provides a process for manufac... |
|
2023
|
Invention
|
Breath actuated inhaler.
A breath actuated metered dose inhaler including a housing, a canister ... |
|
|
Invention
|
Breath actuated inhaler |
|
|
Invention
|
Breath actuated inhaler. A breath actuated metered dose inhaler including a housing, a canister a... |
|
|
P/S
|
pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contr... |
|
|
Invention
|
Slow release drospirenone tablet composition. The invention relates to a pharmaceutical compositi... |
|
2022
|
Invention
|
Mammalian cell culture process for recombinant protein production.
The present invention relates... |
|
|
Invention
|
Mammalian cell culture process for recombinant protein production. The present invention relates ... |
|
|
Invention
|
Pharmaceutical composition of low dose vitamin b12. A pharmaceutical composition of low dose Vita... |
|
|
P/S
|
Oral contraceptives |
|
|
Invention
|
Stabilized solid oral pharmaceutical composition of varenicline.
The disclosed invention relates... |
|
|
Invention
|
Stabilized solid oral pharmaceutical composition of varenicline. The disclosed invention relates ... |
|
|
P/S
|
pharmaceuticals, namely, oral contraceptives; oral hormonal contraceptives; contraceptive prepara... |
|
|
P/S
|
Inhalers filled with pharmaceutical preparations for the treatment of respiratory ailments Inhale... |
|
|
Invention
|
Stable liquid formulations of aflibercept. A stable aqueous pharmaceutical formulation suitable f... |
|
|
Invention
|
Pharmaceutical composition of anti-tumour necrosis factor (anti-tnf) agent for management of infe... |
|
|
Invention
|
Substituted bicyclic heterocyclic compounds as prmt5 inhibitors. The invention relates to substit... |
|
|
Invention
|
A process for purification of fc-fusion proteins. The present invention relates to a process for ... |
|
|
P/S
|
Pharmaceuticals, medical and veterinary preparations namely inhaled pharmaceutical preparations f... |
|
|
P/S
|
Inhaler for dispensing medications |
|
|
P/S
|
Inhaler for dispensing medications; |
|
|
Invention
|
Process for the purification of monoclonal antibodies.
The present invention relates to a proces... |
|
|
Invention
|
Pharmaceutical combinations of sos1 inhibitors for treating and/or preventing cancer.
This discl... |
|
|
Invention
|
Pharmaceutical combinations of sos1 inhibitors for treating and/or preventing cancer. This disclo... |
|
2021
|
Invention
|
Oral pharmaceutical compositions of remdesivir. Disclosed herein are novel pharmaceutical composi... |
|
|
Invention
|
Ophthalmic nanoemulsion compositions.
The present invention relates to sterile pharmaceutical na... |
|
|
Invention
|
Pharmaceutical compositions of raltegravir. A solid pharmaceutical composition for oral administr... |
|
|
Invention
|
Methods, processes and intermediates for preparing chroman compounds. This disclosure describes a... |
|
2020
|
Invention
|
Pharmaceutical composition of casr modulators and methods and uses thereof.
The invention provid... |
|
|
Invention
|
Substituted nucleoside analogs as prmt5 inhibitors. The invention relates to substituted nucleosi... |
|
|
Invention
|
Substituted tricyclic compounds. 5, X, Y, m, and n are as defined herein, for use as SOS1 inhibit... |
|
|
Invention
|
Process for preparing chroman compounds. A process for manufacturing substituted chroman compound... |
|
|
Invention
|
Pharmaceutical combination of prmt5 inhibitors. This disclosure relates to pharmaceutical combina... |
|
|
Invention
|
Event status apparatuses and related devices, systems, and methods. Provided herein are new devic... |
|
|
Invention
|
Modified dosing of vegf inhibitors for ophthalmic use.
The present invention provides a method o... |
|
|
Invention
|
Macrocyclic compounds as sting agonists and methods and uses thereof. Disclosed are macrocyclic c... |
|
|
Invention
|
Prmt5 inhibitors. The invention relates to substituted nucleoside analogues of formula (I), pharm... |
|
|
Invention
|
Macrocyclic compounds as sting agonists. Disclosed are the macrocyclic compounds having the gener... |
|
2017
|
P/S
|
Pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; contr... |
|
|
P/S
|
Pharmaceuticals, namely, oral contraceptives; oral hormonal contraceptives; hormonal agents for t... |
|
2014
|
P/S
|
Inhalers for dispensing medications |
|
|
P/S
|
inhalers, sold empty, for dispensing medications |
|
|
P/S
|
Inhaler for dispensing medications. |
|
2013
|
P/S
|
[ Pharmaceuticals, namely, contraceptives; oral contraceptives; oral hormonal contraceptives; con... |
|
2010
|
P/S
|
Reagents for medical, biological and pharmaceutical research use; medicinal and pharmaceutical pr... |
